Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|17|6|550-558

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.17, Iss.6, 2016-05, pp. : 550-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HRT: protective effects linked to RAAS and bradykinin

By  

Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Secretory organelles in ECL cells: effects of pharmacological blockade of the gastrin/CCK 2 receptor versus its elimination by gene targeting

By Zhao Chun-Mei  

Inflammopharmacology, Vol. 13, Iss. 1-3, 2005-08 ,pp. : 75-82

VSP

Access to resources Recommend Favorite

Novel approaches to the pharmacological blockade of gastric acid secretion

By Parsons Michael E   Keeling David J  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 4, 2005-04 ,pp. : 411-421

Informa Healthcare

Access to resources Recommend Favorite

An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy

By García-Donaire Jose Antonio   Segura Julian   Ruilope Luis Miguel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1587-1596

Informa Healthcare

Access to resources Recommend Favorite

Dietary Antioxidants as Potential Pharmacological Agents for Ischemic Stroke

By  

Current Medicinal Chemistry, Vol. 15, Iss. 12, 2008-05 ,pp. : 1236-1248

Bentham Science Publishers

Access to resources Recommend Favorite